Publications in collaboration with researchers from Hospital Virgen del Camino (12)

2023

  1. RECALSEEN 2021. Resources and quality in the Endocrinology and Nutrition units of the National Health System of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 459-467

2022

  1. How the COVID-19 pandemic has affected the training of Endocrinology and Nutrition Residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 219-226

  2. Multidisciplinary consensus on nutritional and metabolic therapy in enhanced recovery after abdominal surgery programs: NutRICA Project

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 2, pp. 98-111

  3. Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320

2020

  1. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

2019

  1. Preoperative predictive model for acute kidney injury after elective cardiac surgery: A prospective multicenter cohort study

    Minerva Anestesiologica, Vol. 85, Núm. 1, pp. 34-44

2018

  1. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

2017

  1. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501

2016

  1. Home Parenteral Nutrition in Spain, 2015. Home and Ambulatory Artificial Nutrition (NADYA) Group report

    Nutricion Hospitalaria, Vol. 33, Núm. 6, pp. 1487-1490

2006

  1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326

2003

  1. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage

    Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481

2002

  1. Características de la versión española del cuestionario de calidad de vida QLSM-H en sujetos adultos con deficiencia de hormona de crecimiento tratados con somatotropina. Estudio piloto

    Endocrinologia y Nutricion, Vol. 49, Núm. 4, pp. 105-112